![Teva looks to sell generics in China through joint venture with Guangzhou Pharma: Bloomberg | Fierce Pharma Teva looks to sell generics in China through joint venture with Guangzhou Pharma: Bloomberg | Fierce Pharma](https://qtxasset.com/quartz/qcloud5/media/image/FiercePharma-1509981669/Teva.jpg/Teva.jpg?VersionId=0TBMh3DUX_V6QKJz.7BmNcSdN9_moAst)
Teva looks to sell generics in China through joint venture with Guangzhou Pharma: Bloomberg | Fierce Pharma
![COVID-19 Response. ACCIÓ Business Marketplace | Interreg Europe - Sharing solutions for better policy COVID-19 Response. ACCIÓ Business Marketplace | Interreg Europe - Sharing solutions for better policy](https://interregeurope.eu/sites/default/files/styles/banner_image/public/good_practices/good_practice__3932__1590536185.png?itok=HvoTspGO)
COVID-19 Response. ACCIÓ Business Marketplace | Interreg Europe - Sharing solutions for better policy
Teva Pharmaceuticals and IBM Partner to Build Global e-Health Solutions on the IBM Watson Health Cloud
![ADDING MULTIMEDIA Teva Announces U.S. Approval of AJOVYTM (fremanezumab-vfrm) Injection, the First and Only Anti-CGRP Treatment with Both Quarterly and Monthly Dosing for the Preventive Treatment of Migraine in Adults | Business ADDING MULTIMEDIA Teva Announces U.S. Approval of AJOVYTM (fremanezumab-vfrm) Injection, the First and Only Anti-CGRP Treatment with Both Quarterly and Monthly Dosing for the Preventive Treatment of Migraine in Adults | Business](https://mms.businesswire.com/media/20180914005613/en/678526/5/AJOVY+Image.jpg)